Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERENUMAB vs ERTUGLIFLOZIN PIDOLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERENUMAB vs ERTUGLIFLOZIN PIDOLATE: Safety Overview

Metric ERENUMAB ERTUGLIFLOZIN PIDOLATE
Total FAERS Reports 1,183 681
Deaths Reported 363 4
Death Rate 30.7% 0.6%
Hospitalizations 498 128
Average Patient Age 45.6 yrs 57.0 yrs
% Female Patients 93.4% 56.1%
Manufacturer Amgen Inc Merck Sharp & Dohme LLC
Route SUBCUTANEOUS ORAL